trivalent GPC vaccine (Medigen)

N/A

Report date: 2025/01/26 17:54:17

Base Information

Drug Nametrivalent GPC vaccine (Medigen)
Drug Alias Nametrivalent glycoprotein vaccine (Medigen)
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsArenavirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedigen Inc
Inactive CompaniesN/A
Active IndicationsArenavirus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A